已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Discovery of agonists for orphan GPR52 using a ligand-based pharmacophore model and virtual screening

药效团 虚拟筛选 G蛋白偶联受体 腺苷酸环化酶 化学 生物信息学 兴奋剂 配体(生物化学) 效力 部分激动剂 HEK 293细胞 药物发现 反激动剂 立体化学 药理学 受体 计算生物学 生物化学 医学 生物 体外 基因
作者
Hudson R. Smith,Ryan M. Murphy,Michelle A. Hagenimana,John Allen
出处
期刊:Journal of Pharmacology and Experimental Therapeutics [American Society for Pharmacology and Experimental Therapeutics]
卷期号:: 294-294
标识
DOI:10.1124/jpet.294.130118
摘要

Abstract ID 130118 Poster Board 294 GPR52 is an orphan G protein-coupled receptor (GPCR) that is a promising target for neuropsychiatric disorders including schizophrenia and substance abuse disorders. GPR52 is a constitutively active receptor that couples to Gs/olf G proteins to stimulate adenylyl cyclase and increase intracellular cAMP. As with most understudied GPCRs, there is a paucity of structural diversity among known GPR52 ligands. To expand the chemical space of GPR52 ligands, we utilized a proprietary ligand based-pharmacophore model and virtual screening method to identify new potential compounds for GPR52. Greater than 500k synthesis-ready compounds were screened in silico for their structural similarity to the GPR52 agonist c17. This screening provided a compound priority list of 400 predicted GPR52 ligands. These priority compounds were obtained and subsequently screened at 10 μM using a Glosensor cAMP assay in HEK293 cells expressing human GPR52. The primary screen showed 21 hit compounds activated GPR52 cAMP signaling at > 40% of the maximal response to the positive control agonist 4-(3-(3-fluoro-5-(trifluoromethyl) benzyl)-5-methyl-1H-1,2,4-triazol-1-yl)-2-methylbenzamide (FTBMT). Subsequent re-testing confirmed activities, and the five most active compounds were evaluated in concentration responses to determine potency (EC50) and efficacy (Emax). All five compounds exhibited low micromolar potency (ranging from 1.6 to 4.0 μM) and were partial agonists when compared to FTBMT. Two promising validated compounds included 2-B3 (N-(5-{[3-(trifluoromethyl)phenyl]methyl}-1,3-thiazol-2-yl)cyclopropanecarboxamide) and 5-E1 (ethyl 2-benzyl-4-methyl-1,3-thiazole-5-carboxylate). Compound 2-B3 showed lower partial agonist activity (Emax = 39 ± 2%) with a potency (pEC50) of 5.80 ± 0.07 [1.6 μM]. Compound 5-E1 showed moderate partial agonist activity (Emax = 71 ± 2%) and potency (pEC50) of 5.47 ± 0.02 [3.4 μM]. 2-B3 was docked into the previously solved GPR52 crystal structure (PBD 6LI0) using AMDock program. 2-B3 docked into a similar binding site as the agonist c17, with potential hydrogen bonding at the ECL2 amino acid D188. Structural derivatives of agonist 2-B3 are being actively screened to define structure activity relationships important for GPR52 potency and efficacy. Taken together, this virtual screening with pharmacological validation provides a viable method for the discovery of ligands for orphan GPCRs. Compounds 2-B3 and 5-E1 are promising GPR52 agonist ligands amenable to further chemical optimization to expand ligand diversity for GPR52. This work was supported in part by grant# T32DA007287 from the National Institutes of Health and the UTMB Center for Addiction Sciences and Therapeutics.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
万能图书馆的应助被Dyeing采纳,获得10
1秒前
小马甲的应助被奶斯采纳,获得10
1秒前
潇洒的炳发布了新的文献求助10
1秒前
17793654973完成签到 ,获得积分10
1秒前
欸巧克力豆完成签到,获得积分10
1秒前
biubiu发布了新的文献求助10
3秒前
CGDAZE完成签到,获得积分10
4秒前
orixero的应助被keggin采纳,获得10
4秒前
6秒前
SavvyYung完成签到,获得积分10
6秒前
wuyy完成签到,获得积分20
6秒前
冷酷的飞绿完成签到,获得积分10
8秒前
8秒前
9秒前
我是老大的应助被wuyy采纳,获得10
10秒前
10秒前
Orange的应助被粉色热狗采纳,获得10
10秒前
牧青发布了新的文献求助10
11秒前
神勇的又槐完成签到,获得积分10
12秒前
13秒前
13秒前
WLJlele发布了新的文献求助10
14秒前
无极微光的应助被ccccelia采纳,获得20
14秒前
Dyeing发布了新的文献求助10
15秒前
炙热含之完成签到,获得积分10
16秒前
16秒前
阿南发布了新的文献求助10
17秒前
17秒前
万能图书馆的应助被喜悦乐巧采纳,获得10
18秒前
科研通AI6.3的应助被符聪采纳,获得10
18秒前
18秒前
诸葛明明的应助被积极的凌文采纳,获得10
19秒前
玄牝完成签到,获得积分10
19秒前
原神大王发布了新的文献求助10
20秒前
YHQ发布了新的文献求助10
21秒前
邱邱科研发布了新的文献求助10
21秒前
wuyy发布了新的文献求助10
22秒前
22秒前
大模型的应助被大眼的平松采纳,获得10
22秒前
Xu发布了新的文献求助10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189671
求助须知:如何正确求助?哪些是违规求助? 9576938
关于积分的说明 21850391
捐赠科研通 7787625
什么是DOI,文献DOI怎么找? 3435756
关于科研通互助平台的介绍 2559813
邀请新用户注册赠送积分活动 2482624